high dose radiation
Showing 1 - 25 of >10,000
Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Standard systemic therapy + radiotherapy
- Standard systemic therapy
-
Gothenburg, Sweden
- +5 more
Nov 17, 2023
Cholangiocarcinoma Trial in Navi Mumbai (High Dose Radiation, Systemic chemo)
Recruiting
- Cholangiocarcinoma
- High Dose Radiation
- Systemic chemotherapy
-
Navi Mumbai, Maharashtra, IndiaAdvanced Centre of Treatment Research and Education In Cancer,Ta
Oct 20, 2022
Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)
Not yet recruiting
- Prostatic Cancer
- High Dose Brachytherapy
- Stereostatic Body Radiation Therapy
- (no location specified)
Mar 3, 2023
Early Lung Cancer, Stereotactic Body Radiotherapy Trial in Peking (SBRT)
Not yet recruiting
- Early Lung Cancer
- Stereotactic Body Radiotherapy
- SBRT
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Mar 26, 2023
Prostate Cancer Trial in London (177Lu-PNT2002, High Dose Radiation)
Recruiting
- Prostate Cancer
- 177Lu-PNT2002
- High Dose Radiation
-
London, Ontario, CanadaLondon Health Sciences Centre
Nov 22, 2022
Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)
Recruiting
- Colorectal Liver Metastases
- Radiation: High- and Low-dose radiotherapy
- PD-1 Inhibitors
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Sep 13, 2023
Metastatic Tumor to the Spine, Metastatic Tumor Trial in Cleveland (Conventional external beam radiation therapy dose (EBRT),
Recruiting
- Metastatic Neoplasm to the Spine
- Metastatic Neoplasm
- Conventional external beam radiation therapy dose (EBRT)
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 24, 2023
Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC
Recruiting
- Prostate Adenocarcinoma
- +7 more
- High-Dose Rate Brachytherapy
- Stereotactic Body Radiation Therapy
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022
Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8 Trial in Atlanta
Recruiting
- Stage III Prostate Cancer AJCC v8
- +3 more
- High-Dose Rate Brachytherapy
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jul 8, 2022
High Grade Sarcoma Trial in Tampa (Intensity Modulated Radiation Therapy (IMRT), MRI)
Recruiting
- High Grade Sarcoma
- Intensity Modulated Radiation Therapy (IMRT)
- MRI
-
Tampa, FloridaMoffitt Cancer Center
Aug 16, 2022
Prostate Cancer Trial in Milwaukee (Radiation Therapy)
Recruiting
- Prostate Cancer
- Radiation Therapy
-
Milwaukee, WisconsinFroedtert Hospital
Mar 8, 2022
DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,
Not yet recruiting
- DLBCL - Diffuse Large B Cell Lymphoma
- +6 more
- Bridging radiation therapy
- +2 more
- (no location specified)
Jan 4, 2023
Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by
Recruiting
- Recurrent High-grade Glioma
- +3 more
- 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
- +2 more
-
Incheon, Korea, Republic ofGachon University Gil Medical Center
Feb 19, 2023
Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)
Not yet recruiting
- Neoplasms
- +7 more
- Biological G207
-
Birmingham, AlabamaChildren's of Alabama
Jun 1, 2022
Cervical Cancer, Endometrial Cancer, Esophageal Cancer Trial run by the National Cancer Institute (NCI) (HDR Brachytherapy)
Recruiting
- Cervical Cancer
- +4 more
- HDR Brachytherapy
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 19, 2022
Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph
Recruiting
- Triple Negative Breast Cancer
- +2 more
- Radiation Therapy Boost
- +6 more
-
Washington, District of Columbia
- +8 more
Dec 5, 2022
Metastatic Melanoma Trial in Portland (Radiation therapy and high-dose IL-2, High-dose IL-2)
Active, not recruiting
- Metastatic Melanoma
- Radiation therapy and high-dose IL-2
- High-dose IL-2
-
Portland, OregonProvidence Cancer Center
Sep 23, 2021
Prostate Cancer Trial in United States (Radiation Therapy)
Recruiting
- Prostate Cancer
- Radiation Therapy
-
Basking Ridge, New Jersey
- +6 more
Nov 16, 2021
Renal Cell Carcinoma Trial in Portland (High Dose IL-2, SBRT)
Active, not recruiting
- Renal Cell Carcinoma
- High Dose IL-2
- SBRT
-
Portland, OregonPortland Providence Medical Center
Jan 31, 2022
Pancreatic Cancer Trial in Baltimore (High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT))
Recruiting
- Pancreatic Cancer
- High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT)
-
Baltimore, MarylandJohns Hopkins Hospital
Jun 3, 2022
Endometrial Cancer Trial in Oklahoma City (Pembrolizumab, Vaginal cuff brachytherapy (VCB), Paclitaxel)
Recruiting
- Endometrial Cancer
- Pembrolizumab
- +3 more
-
Oklahoma City, OklahomaStephenson Cancer Center
Jan 9, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Hamilton, London, Toronto (High-Dose Cisplatin, Low-Dose
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- High-Dose Cisplatin
- +2 more
-
Hamilton, Ontario, Canada
- +2 more
Jun 7, 2022
Hepatocellular Carcinoma Trial in Seoul (radiation, drug, other)
Completed
- Hepatocellular Carcinoma
- Low radiation dose CT
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 29, 2022
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)
Active, not recruiting
- Prostate Adenocarcinoma
- +4 more
- Internal Radiation Therapy
- +7 more
-
Stanford, CaliforniaStanford University, School of Medicine
Feb 1, 2022